176 research outputs found
Modification, Synthesis, and Analysis of Advanced Materials Using Ion Beam Techniques
Energetic ion beams are employed for the synthesis, modification, and analysis of advanced, technologically important materials, and many novel applications have emerged over the past several decades. The evolution of the field over this period is recorded in a broad range of conferences that are dedicated to particular aspects of ion-beam modification or analysis of materials, including international conferences on ion beam modification of materials (IBMM), ion beam analysis (IBA), surface modification of materials by ion beams (SMMIB), and so forth. This special issue aims to present some of the latest results in the field
La metodología de la investigación en Traductología
Empirical research methods in Translation Studies have been used in Spain for a decade. A glimpse of the most recent studies carried out in our country is given, as well as the actual trends in research. A research methodology based on the scientific method is proposed, and a research design to study the acquisition of translation competence in trainees is presented, including three original measuring instruments created for the study: the first instrument measures the translation notions of the students; the second one measures students' performance when faced with translation problems; and the third one measures performance regarding translation errors
Production of Medical Radioisotopes with High Specific Activity in Photonuclear Reactions with Beams of High Intensity and Large Brilliance
We study the production of radioisotopes for nuclear medicine in
photonuclear reactions or ()
photoexcitation reactions with high flux [()/s], small
diameter m and small band width () beams produced by Compton back-scattering of laser
light from relativistic brilliant electron beams. We compare them to (ion,np) reactions with (ion=p,d,) from particle accelerators like
cyclotrons and (n,) or (n,f) reactions from nuclear reactors. For
photonuclear reactions with a narrow beam the energy deposition in the
target can be managed by using a stack of thin target foils or wires, hence
avoiding direct stopping of the Compton and pair electrons (positrons).
isomer production via specially selected cascades
allows to produce high specific activity in multiple excitations, where no
back-pumping of the isomer to the ground state occurs. We discuss in detail
many specific radioisotopes for diagnostics and therapy applications.
Photonuclear reactions with beams allow to produce certain
radioisotopes, e.g. Sc, Ti, Cu, Pd, Sn,
Er, Pt or Ac, with higher specific activity and/or
more economically than with classical methods. This will open the way for
completely new clinical applications of radioisotopes. For example Pt
could be used to verify the patient's response to chemotherapy with platinum
compounds before a complete treatment is performed. Also innovative isotopes
like Sc, Cu and Ac could be produced for the first time
in sufficient quantities for large-scale application in targeted radionuclide
therapy.Comment: submitted to Appl. Phys.
Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10
Background:The human epidermal growth factor receptor (EGFR) is an important therapeutic target in oncology, and three different types of EGFR inhibitors have been approved for the treatment of cancer patients. However, there has been no clear association between the expression levels of EGFR protein in the tumours determined by the FDA-approved EGFR PharmDx kit (Dako) or other standard anti-EGFR antibodies and the response to the EGFR inhibitors.Method:In this study, we investigated the potential of our anti-EGFR monoclonal antibodies (mAbs; ICR9, ICR10, ICR16) for immunohistochemical diagnosis of wild-type EGFR and/or the type-III deletion mutant form of EGFR (EGFRvIII) in formalin-fixed, paraffin-embedded human tumour specimens.Results:We found that the anti-EGFR mAb in the EGFR PharmDx kit stained both wild-type and EGFRvIII-expressing cells in formalin-fixed, paraffin-embedded sections. This pattern of EGFR immunostaining was also found with our anti-EGFR mAb ICR16. In contrast, mAbs ICR10 and ICR9 were specific for the wild-type EGFR.Conclusion:We conclude that mAbs ICR9 and ICR10 are ideal tools for investigating the expression patterns of wild-type EGFR protein in tumour specimens using immunohistochemistry, and to determine their prognostic significance, as well as predictive value for response to therapy with EGFR antibodies.British Journal of Cancer advance online publication, 7 February 2012; doi:10.1038/bjc.2012.27 www.bjcancer.com
Targeted therapies in colorectal cancer: an integrative view by PPPM
In developed countries, colorectal cancer (CRC) is the third most common malignancy, but it is the second most frequent cause of cancer-related death. Clinicians are still faced with numerous challenges in the treatment of this disease, and future approaches which target the molecular features of the disorder will be critical for success in this disease setting. Genetic analyses of many solid tumours have shown that up to 100 protein-encoding genes are mutated. Within CRC, numerous genetic alterations have been identified in a number of pathways. Therefore, understanding the molecular pathology of CRC may present information on potential routes for treatment and may also provide valuable prognostic information. This will be particularly pertinent for molecularly targeted treatments, such as anti-vascular endothelial growth factor therapies and anti-epidermal growth factor receptor (EGFR) monoclonal antibody therapy. KRAS and BRAF mutations have been shown to predict response to anti-EGFR therapy. As EGFR can also signal via the phosphatidylinositol 3-kinase (PI3K) kinase pathway, there is considerable interest in the potential roles of members of this pathway (such as PI3K and PTEN) in predicting treatment response. Therefore, a combined approach of new techniques that allow identification of these biomarkers alongside interdisciplinary approaches to the treatment of advanced CRC will aid in the treatment decision-making process and may also serve to guide future therapeutic approaches
Outgassing and degradation of polyimide induced by swift heavy ion irradiation at cryogenic temperature
International audiencePolyimide foils were irradiated with energetic Kr (740 MeV) and Pb (890 MeV) ions at cryogenic temperature (12 K). Beam-induced degradation processes were monitored by residual gas analysis and online infrared spectroscopy. The outgassing components observed at low irradiation temperatures differ in quantity but are similar in mass distribution to those identified at room temperature exposure. Besides CO as major volatile fragment, a significant contribution of short hydrocarbons like C2Hx is released. In situ infrared spectroscopy indicates accumulation of CO and CO2 molecules at 12 K in the foils. During heat-up cycles, most of these frozen gases become mobile and outgas at a temperature between 35 and 55 K. The study is motivated by the application of polyimide foils as insulating material in high radiation environment of the future accelerator facility for antiproton and ion research (FAIR)
- …